PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25226N0135Japanese encephalitis VIRUS vaccine IXIARO — Valneva Usa, Inc

Valneva Usa, Inc holds $89.2M across 39 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

252-Network Contract Office 12 (36C252)

Awarding office

Valneva Usa, Inc

Recipient

Sep 30, 2026

PoP end

$720K

Obligated

$720K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Valneva Usa, Inc — $90

Contract facts

Federal

Contract number36C25226N0135

Also listed as36C252-26-N-0135

Also listed as36F79725D0249-36C25226N0135

Agency252-Network Contract Office 12 (36C252)

Awarding office252-Network Contract Office 12 (36C252)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentValneva Usa, Inc

CAGE43FM1

UEINT38AFWQNKM7

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79725D0249

Place of performanceBETHESDA MD

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startNov 1, 2025

PoP end (current)Sep 30, 2026

Obligated$720K

Current value$720K

Potential value$720K

JAPANESE ENCEPHALITIS VIRUS VACCINE IXIARO is a federal award for 252-Network Contract Office 12 (36C252) held by Valneva Usa, Inc. Estimated value $720K ($720K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: BETHESDA MD.

JAPANESE ENCEPHALITIS VIRUS VACCINE IXIARO

Recompete timing

Public

● Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Valneva Usa, Inc — $89.2M obligated across 39 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($89.2M) · all agencies

Department of Defense (DOD)$86.4M · 97%Department of Veterans Affairs (VA)$2.0M · 2%Department of Health and Human Services (HHS)$675K · 1%Department of Justice (DOJ)$100K · 0%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25226N0135?

36C25226N0135 (Japanese encephalitis VIRUS vaccine IXIARO) is a 252-Network Contract Office 12 (36C252) award with a potential value of $720K, currently held by Valneva Usa, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C252-26-N-0135?

36C252-26-N-0135 is the dashed form of PIID 36C25226N0135 (Japanese encephalitis VIRUS vaccine IXIARO), held by Valneva Usa, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25226N0135?

252-Network Contract Office 12 (36C252) awarded 36C25226N0135 to Valneva Usa, Inc (potential $720K).

Who is the incumbent on 36C25226N0135?

Valneva Usa, Inc is the incumbent with $89.2M across 39 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Valneva Usa, Inc’s 36C25226N0135 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Jan 8, 2026